Literature DB >> 11701223

Nicotine inhibits UV-induced activation of the apoptotic pathway.

N Sugano1, T Minegishi, K Kawamoto, K Ito.   

Abstract

Although nicotine has been implicated as a potential factor in the pathogenesis of cancer in humans, its mechanism of action in the development of cancer remains largely unknown. Growing evidence indicates that the induction of apoptosis is an important mechanism in the prevention of cancer development. In the study presented here, we examined the effects of nicotine on the process of apoptosis. Preincubation of human cells with nicotine completely inhibited ultraviolet light (UV)-induced apoptosis. The inhibition of apoptosis by nicotine was correlated with the prevention of cytochrome c release and caspase activation, which are essential components of the UV-induced apoptotic pathway. Thus, our results suggest that the inhibition of apoptosis by nicotine contributes to the increased incidence of cancer in smokers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701223     DOI: 10.1016/s0378-4274(01)00416-7

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  11 in total

1.  [Effects of nicotine with special consideration given to tumorigenesis in the head and neck region].

Authors:  M P Semmler; O Driemel; R Staudenmaier; K Froelich; N H Kleinsasser
Journal:  Mund Kiefer Gesichtschir       Date:  2006-11

2.  Cytogenetic biomonitoring of oral mucosa cells from adults exposed to dental X-rays.

Authors:  Daniel A Ribeiro; Fernanda Angelieri
Journal:  Radiat Med       Date:  2008-08-03

3.  Biomonitoring of oral epithelial cells in smokers and non-smokers submitted to panoramic X-ray: comparison between buccal mucosa and lateral border of the tongue.

Authors:  Fernanda Angelieri; Tatiana de Cássia Gonçalves Moleirinho; Viviane Carlin; Celina Tizuko Fujiyama Oshima; Daniel Araki Ribeiro
Journal:  Clin Oral Investig       Date:  2009-10-02       Impact factor: 3.573

4.  Cytogenetic biomonitoring of oral mucosa cells of crack cocaine users.

Authors:  Maria das Graças Alonso de Oliveira; Jean Nunes Dos Santos; Patrícia Ramos Cury; Victor Hugo Pereira da Silva; Nara Rejane Cruz Oliveira; Ricardo da Costa Padovani; Adriana Marcassa Tucci; Daniel Araki Ribeiro
Journal:  Environ Sci Pollut Res Int       Date:  2014-01-16       Impact factor: 4.223

5.  Receptor-mediated tobacco toxicity: regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Lisa M Marubio; Arthur L Beaudet; David L Jolkovsky; Kent E Pinkerton; Sergei A Grando
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer.

Authors:  Jingmei Zhang; Opal Kamdar; Wei Le; Glenn D Rosen; Daya Upadhyay
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-01       Impact factor: 6.914

Review 7.  Glycogen synthase kinase 3 beta: can it be a target for oral cancer.

Authors:  Rajakishore Mishra
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

8.  Genotoxicity and cytotoxicity induced by municipal effluent in multiple organs of Wistar rats.

Authors:  Victor Hugo Pereira da Silva; Carolina Foot Gomes de Moura; Flavia Andressa Pidone Ribeiro; Augusto Cesar; Camilo Dias Seabra Pereira; Marcelo Jose Dias Silva; Wagner Vilegas; Daniel Araki Ribeiro
Journal:  Environ Sci Pollut Res Int       Date:  2014-07-05       Impact factor: 4.223

9.  Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study.

Authors:  Robert P Murray; John E Connett; Lisa M Zapawa
Journal:  Nicotine Tob Res       Date:  2009-07-01       Impact factor: 4.244

10.  Nicotine-mediated signals modulate cell death and survival of T lymphocytes.

Authors:  Silvia C S Oloris; Ashley A Frazer-Abel; Cristan M Jubala; Susan P Fosmire; Karen M Helm; Sally R Robinson; Derek M Korpela; Megan M Duckett; Shairaz Baksh; Jaime F Modiano
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-04       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.